P4ML Joins Orphan Therapeutics Accelerator to Enhance Rare Disease Treatment Access P4ML has become a Founding Member of the OTXL to improve global access to treatments for ultra-rare diseases, leveraging innovative strategies.

P4ML Joins Orphan Therapeutics Accelerator to Enhance Rare Disease Treatment Access #Dubai #UAE #P4ML #OTXL #Genomic_Therapy